Toll Free: 1-888-928-9744

Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single Injection, Three Injection, Five Injection), By Region, And Segment Forecasts, 2019 - 2026

Published: May, 2019 | Pages: 155 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global viscosupplementation market size is expected to reach USD 7.1 billion by 2026, based on a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 9.11% during the forecast period. The market is expected to observe an exponential growth attributed to the increasing incidence of osteoarthritis, wounds, gingivitis, and ulcers coupled with growing geriatric population.

Estimates published by the World Health Organization (WHO) suggest that the global population of the age group 65 years and above is anticipated to rise from 7% in 2000 to 16% in 2050. A consequence of this growth in geriatric population will be the rise in prevalence of obesity and osteoarthritis. Along with the growing preference for minimally invasive surgeries, a global increase in the target population is expected to significantly propel demand for viscosupplementations throughout the forecast period.

Further key findings from the study suggest:

• Three injections segment led the market in 2018, closely followed by the single injection segment. This growth can be accredited to the prolonged presence and holding a significant market share

• Single injection segment is anticipated to be one of the fastest growing segments owing to the benefits of the product such as increased convenience and reduced hospital visits and adverse effects such as pain

• Geographically, Asia Pacific held the largest market share in 2018 and is expected to maintain its position during the forecast period, owing to the presence of a sizeable geriatric population, which is more susceptible to disorders such as osteoarthritis and rheumatoid arthritis. Moreover, the growing demand for minimally invasive procedures is a significant factor contributing to the regional growth

• Due to the presence of high unmet medical needs, growing awareness about applications of minimally invasive techniques, and increasing disposable income; Europe viscosupplementation market is expected to grow at a lucrative CAGR in the forthcoming years

• Some key industry contributors are Sanofi; Anika Therapeutics, Inc.; Seikagaku Corporation; Zimmer Holdings Inc.; Bioventus; Ferring B.V.; Lifecore Biomedical, LLC; and LG Life Sciences Ltd
 Table of Contents

Chapter 1 Research Methodology
                   1.1 Information Procurement
                   1.2 Data Analysis

Chapter 2 Executive Summary
                   2.1 Market Snapshot
                   2.2 Segment Outlook
                       2.2.1 By Product
                   2.3 Competitive Insights

Chapter 3 Viscosupplementation Market Variables, Trends & Scope
                   3.1 Market lineage outlook
                       3.1.1 Parent Market Outlook
                       3.1.2 Related/Ancillary Market Outlook
                   3.2 Market Segmentation and Scope
                   3.3 User Perspective Analysis
                       3.3.1 Consumer Behaviour Analysis
                       3.3.2 Market Influencer Analysis
                   3.4 Market Dynamics
                       3.4.1 Market Driver Analysis
                           3.4.1.1 Increasing prevalence of osteoarthritis among geriatric population
                           3.4.1.2 New product development
                               3.4.1.2.1 Some of the recently launched products are as follows
                       3.4.2 Market Restraint Analysis
                           3.4.2.1 High cost and side effects associated with hyaluronic acid cycles
                   3.5 Viscosupplementation: Market Analysis Tools
                       3.5.1 Industry Analysis - Porter’s
                       3.5.2 Viscosupplementation Market - Pestle Analysis
                       3.5.3 Major Deals & Strategic Alliances Analysis
                           3.5.3.1 Joint ventures, mergers & acquisition
                           3.5.3.2 Licensing & partnership, technology collaborations
                   3.6 Penetration & Growth Prospects Mapping

Chapter 4 Viscosupplementation Market: Product Estimates & Trend Analysis
                   4.1 Viscosupplementation Market: Product Movement Analysis
                   4.2 Single Injection
                       4.2.1 Single-Injection Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                   4.3 Three Injection
                       4.3.1 Three-Injection Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                   4.4 Five Injection
                       4.4.1 Five-Injection Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                   4.5 Product Information
                       4.5.1 Durolane
                       4.5.2 Gelsyn-3
                       4.5.3 Genvisc 850
                       4.5.4 Hymovis
                       4.5.5 Supartz Fx
                       4.5.6 Trivisc
                       4.5.7 Visco-3
                       4.5.8 Ostenil
                       4.5.9 Adant

Chapter 5 Viscosupplementation Market: Regional Estimates & Trend Analysis, by Product
                   5.1 Regional Market Dashboard
                   5.2 Viscosupplementation Market Share, by Region, 2018 & 2026
                   5.3 Regional Market Share Analysis, 2018 & 2026
                   5.4 SWOT Analysis, by Factor
                       5.4.1 North America
                       5.4.2 Europe
                       5.4.3 Asia Pacific
                       5.4.4 Latin America
                       5.4.5 Middle East & Africa
                   5.5 North America
                       5.5.1 U.S.
                           5.5.1.1 Regulatory and reimbursement scenario
                           5.5.1.2 U.S. viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.5.2 Canada
                           5.5.2.1 Regulatory and reimbursement scenario
                           5.5.2.2 Canada viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                   5.6 Europe
                   5.7 Prices of Products in Europe
                       5.7.1 U.K.
                           5.7.1.1 Regulatory and reimbursement Scenario
                           5.7.1.2 U.K. viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.7.2 France
                           5.7.2.1 Regulatory and reimbursement scenario
                           5.7.2.2 France viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.7.3 Germany
                           5.7.3.1 Regulatory and reimbursement scenario
                           5.7.3.2 Germany viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.7.4 Italy
                           5.7.4.1 Regulatory and reimbursement scenario
                           5.7.4.2 Italy viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.7.5 Spain
                           5.7.5.1 Regulatory and reimbursement scenario
                           5.7.5.2 Spain viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                   5.8 Asia Pacific
                       5.8.1 Asia Pacific Viscosupplementation Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                       5.8.2 China
                           5.8.2.1 Regulatory and reimbursement scenario
                           5.8.2.2 China viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.8.3 Japan
                           5.8.3.1 Regulatory and reimbursement scenario
                           5.8.3.2 Japan viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.8.4 India
                           5.8.4.1 Regulatory and reimbursement scenario
                           5.8.4.2 India viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.8.5 South Korea
                           5.8.5.1 Regulatory and reimbursement scenario
                           5.8.5.2 South Korea viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.8.6 Australia
                           5.8.6.1 Regulatory and reimbursement scenario
                           5.8.6.2 Australia viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                   5.9 Latin America
                       5.9.1 Regulatory And Reimbursement Scenario
                       5.9.2 Latin America Viscosupplementation Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                       5.9.3 Brazil
                           5.9.3.1 Regulatory and reimbursement scenario
                           5.9.3.2 Brazil viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.9.4 Mexico
                           5.9.4.1 Regulatory and reimbursement scenario
                           5.9.4.2 Mexico viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.9.5 Argentina
                           5.9.5.1 Regulatory and reimbursement scenario
                           5.9.5.2 Argentina viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.9.6 Colombia
                           5.9.6.1 Colombia viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                   5.10 MEA
                       5.10.1 MEA Viscosupplementation Market Estimates And Forecasts, 2015 - 2026 (USD Million)
                       5.10.2 South Africa
                           5.10.2.1 Regulatory and reimbursement scenario
                           5.10.2.2 South Africa viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.10.3 Saudi Arabia
                           5.10.3.1 Regulatory and reimbursement scenario
                           5.10.3.2 Saudi Arabia viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
                       5.10.4 UAE
                           5.10.4.1 Regulatory and reimbursement scenario
                           5.10.4.2 UAE viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)

Chapter 6 Reimbursement Outlook
                   6.1 Direct Medical Costs of Treatment of Osteoarthritis (Percentage Distribution)
                   6.2 Costs of Products
                   6.3 Reimbursement by Product
                       6.3.1 Gel-One
                       6.3.2 Euflexxa
                       6.3.3 Synvisc-One
                       6.3.4 Supartz
                       6.3.5 Hyalgan
                       6.3.6 Monovisc
                       6.3.7 Orthovisc

Chapter 7 Competitive Landscape
                   7.1 Clinical Pipeline
                   7.2 Clinical Trials
                   7.3 Recent Developments & Impact Analysis, By Key Market Participants
                   7.4 Vendor Landscape
                       7.4.1 List of key distributors and channel partners
                   7.5 Viscosupplement Competitive Landscape: Market Position Analysis (Based on products, regional presence)
                   7.6 Strategy Framework
                   7.7 Company Profiles
                       7.7.1 Sanofi
                           7.7.1.1 Company overview
                           7.7.1.2 Financial performance
                           7.7.1.3 Product benchmarking
                           7.7.1.4 Strategic initiatives
                           7.7.1.5 SWOT analysis
                       7.7.2 Anika Therapeutics, Inc.
                           7.7.2.1 Company overview
                           7.7.2.2 Financial performance
                           7.7.2.3 Product benchmarking
                           7.7.2.4 Strategic initiatives
                           7.7.2.5 SWOT analysis
                       7.7.3 Seikagaku Corporation
                           7.7.3.1 Company overview
                           7.7.3.2 Financial performance
                           7.7.3.3 Product benchmarking
                           7.7.3.4 Strategic initiatives
                           7.7.3.5 SWOT analysis
                       7.7.4 Zimmer Biomet
                           7.7.4.1 Company overview
                           7.7.4.2 Financial performance
                           7.7.4.3 Product benchmarking
                           7.7.4.4 Strategic initiatives
                           7.7.4.5 SWOT analysis
                       7.7.5 Smith & Nephew PLC
                           7.7.5.1 Company overview
                           7.7.5.2 Financial performance
                           7.7.5.3 Product benchmarking
                           7.7.5.4 Strategic initiatives
                           7.7.5.5 SWOT analysis
                       7.7.6 Ferring B.V.
                           7.7.6.1 Company overview
                           7.7.6.2 Financial performance
                           7.7.6.3 Product benchmarking
                           7.7.6.4 Strategic initiatives
                       7.7.7 Lifecore Biomedical, LLC (Landec)
                           7.7.7.1 Company overview
                           7.7.7.2 Financial performance
                           7.7.7.3 Product benchmarking
                           7.7.7.4 Strategic initiatives
                           7.7.7.5 SWOT analysis
                       7.7.8 LG Life Sciences Ltd
                           7.7.8.1 Company overview
                           7.7.8.2 Financial performance
                           7.7.8.3 Product benchmarking
                           7.7.8.4 Strategic initiatives
                           7.7.8.5 SWOT analysis
                       7.7.9 Salix Pharmaceuticals
                           7.7.9.1 Company overview
                           7.7.9.2 Financial performance
                           7.7.9.3 Product benchmarking
                           7.7.9.4 Strategic initiatives
                           7.7.9.5 SWOT analysis
                       7.7.10 Fidia Farmaceutici S.P.A
                           7.7.10.1 Company overview
                           7.7.10.2 Financial performance
                           7.7.10.3 Product benchmarking
                           7.7.10.4 Strategic initiatives
                       7.7.11 F.Hoffmann-La Roche Ltd.
                           7.7.11.1 Company overview
                           7.7.11.2 Financial performance
                           7.7.11.3 Product benchmarking
                           7.7.11.4 Strategic initiatives
                           7.7.11.5 SWOT analysis

Chapter 8 Recommendations
List of Tables

TABLE 1 North America viscosupplementation market estimates and forecasts, by country, 2015 - 2026 (USD Million)
TABLE 2 North America viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 3 U.S. viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 4 Canada viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 5 Europe viscosupplementation market estimates and forecasts, by country, 2015 - 2026 (USD Million)
TABLE 6 Europe viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 7 U.K. viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 8 France viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 9 Germany viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 10 Italy viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 11 Spain viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 12 Asia Pacific viscosupplementation market estimates and forecasts, by country, 2015 - 2026 (USD Million)
TABLE 13 Asia Pacific viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 14 China viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 15 Japan viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 16 India viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 17 South Korea viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 18 Australia viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 19 Latin America viscosupplementation market estimates and forecasts, by country, 2015 - 2026 (USD Million)
TABLE 20 Latin America viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 21 Brazil viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 22 Mexico viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 23 Argentina viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 24 Colombia viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 25 MEA viscosupplementation market estimates and forecasts, by country, 2015 - 2026 (USD Million)
TABLE 26 MEA viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 27 South Africa viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 28 Saudi Arabia viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 29 UAE viscosupplementation market estimates and forecasts, by product, 2015 - 2026 (USD Million)
TABLE 30 Cost of viscosupplements-a driving factor (U.S.)
TABLE 31 HCPCS codes
TABLE 32 Labelling instructions by the FDA
TABLE 33 Distribution and marketing rights of Synvisc

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing &forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary, 2018 (USD Million)
FIG. 8 Market segmentation & scope
FIG. 9 Market trends & outlook
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Ratio of adult population to total population (billion)
FIG. 12 Market restraint relevance analysis (Current &future impact)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Viscosupplementation market - PESTLE Analysis
FIG. 15 Penetration & growth prospect mapping
FIG. 16 Viscosupplementation market: Product outlook key takeaways (USD Million)
FIG. 17 Viscosupplementation market: Product movement analysis (USD Million)
FIG. 18 Global single-injection market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 19 Global three-injection market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 20 Global five-injection market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 21 Regional market place: Key takeaways
FIG. 22 Regional outlook, 2018 & 2026 (USD Million)
FIG. 23 North America: SWOT analysis
FIG. 24 Europe: SWOT analysis
FIG. 25 Asia Pacific: SWOT analysis
FIG. 26 Latin America: SWOT analysis
FIG. 27 MEA: SWOT analysis
FIG. 28 North America viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 29 U.S. viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 30 Canada viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 31 Europe viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 32 U.K. viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 33 France viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 34 Germany viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 35 Italy viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 36 Spain viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 37 Asia Pacific viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 38 China viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 39 Japan viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 40 India viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 41 South Korea viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 42 Australia viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 43 Latin America viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 44 Brazil viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 45 Mexico viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 46 Argentina viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 47 Colombia viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 48 MEA viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 49 South Africa viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 50 Saudi Arabia viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 51 UAE viscosupplementation market estimates and forecasts, 2015 - 2026 (USD Million)
FIG. 52 Recent developments & impact analysis, by key market participants
FIG. 53 Viscosupplement market: Company market position analysis
FIG. 54 Strategy framework 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $4950
Multi User - US $5950
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify